Sparsha Pharma International Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 28-06-2024
- Paid Up Capital ₹ 8.56 Cr
as on 28-06-2024
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
as on 28-06-2024
- Satisfied Charges ₹ 8.00 Cr
as on 28-06-2024
- Revenue 47.43%
(FY 2021)
- Profit 335.62%
(FY 2021)
- Ebitda 110.75%
(FY 2021)
- Net Worth 14.82%
(FY 2021)
- Total Assets 4.84%
(FY 2021)
About Sparsha Pharma International
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.56 Cr.
The company currently has active open charges totaling ₹5.00 Cr. The company has closed loans amounting to ₹8.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sparsha Pharma International Private Limited India is J Sainathan as COMPANY SECRETARY. Hema Veerapaneni, Bobba Venkatadri, Dange Veerapaneni, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232TG2007PTC052719
- Company No.
052719
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 2007
- Date of AGM
16 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sparsha Pharma International?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dange Veerapaneni  | Managing Director | 11-Apr-2008 | Current |
J Sainathan  | Company Secretary | 27-Jan-2015 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shosaku Murayama  | Director | 23-Nov-2008 | Current |
| Hema Veerapaneni | Director | 07-Sep-2007 | Current |
| Bobba Venkatadri | Director | 11-Apr-2008 | Current |
| Hiroyuki Kubo | Director | 26-Mar-2018 | Current |
Financial Performance and Corporate Structure Insights of Sparsha Pharma International.
Sparsha Pharma International Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 47.43% increase. The company also saw a substantial improvement in profitability, with a 335.62% increase in profit. The company's net worth Soared by an impressive increase of 14.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sparsha Pharma International?
In 2021, Sparsha Pharma International had a promoter holding of 37.57% and a public holding of 62.41%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
A.P.I.D.C. Venture Capital Private LimitedActive 35 years 3 monthsBobba Venkatadri is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 10 Sep 2013 | ₹5.00 Cr | Open |
Technology Developement Board Creation Date: 06 May 2013 | ₹8.00 Cr | Satisfied |
How Many Employees Work at Sparsha Pharma International?
Sparsha Pharma International has a workforce of 77 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sparsha Pharma International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sparsha Pharma International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
